Ubs Asset Management Americas Inc Roivant Sciences Ltd. Put Options Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
330Shares Held
507MCall Options Held
1.14MPut Options Held
2.32M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$711 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$710 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$584 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$382 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.6B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...